We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Critique |

Four Hundred Consecutive Total Gastrectomies for Gastric Cancer—Invited Critique

Nita Ahuja, MD
Arch Surg. 2008;143(8):775. doi:10.1001/archsurg.143.8.775.
Text Size: A A A
Published online


The article by Pacelli et al highlights, once again, the role of high-volume experienced centers in performing complex operations with low morbidity and mortality. The authors are to be commended for their ability to perform TG and pancreas-preserving D2-D3 lymph node dissections with excellent long-term survival (61.8% at 5 years and 47.3% at 10 years). In this study, 95.5% (298 of 312) of patients underwent R0 resection. However, several points required careful attention.

Although TG is no longer considered the standard for gastric cancer, it may be needed in selected patients with proximal lesions or diffuse-type (linitis plastica) gastric cancer to obtain R0 resection.1 However, the extent of lymphadenectomy in gastric cancer remains controversial. The authors routinely performed pancreas-preserving D2-D3 lymphadenectomy for gastric cancer. Data from several randomized trials and meta-analysis have shown no survival benefit of extended lymphadenectomy. The Dutch Gastric Cancer Group has recently published long-term results with 11-year follow-up and confirmed no survival benefit of D2 vs D1 lymph node dissection except for N2 disease on subset analysis.1 Splenectomy and pancreatectomy were shown to be significant risk factors for morbidity and in-hospital mortality after D2 lymph node dissections in randomized trials.1,2 Recent evidence supports the use of the so-called over-D1 lymphadenectomy to obtain adequate lymph nodes for appropriate staging, with selective resection of the pancreas and spleen to obtain R0 resection.1 In addition, the role for palliative TG seems small, given a recent series showing that most patients with distant metastasis do not require any surgical interventions for symptom control.3 In the study by Pacelli et al, palliative TG by experienced surgeons carried substantial mortality of 6.8% and morbidity of 37.5%, with unclear benefits. Most patients (69.3%) undergoing palliative TG received adjuvant chemotherapy, and the authors do not address the contribution of adjuvant therapy. Gastric cancer remains a lethal disease worldwide, and future progress will depend on the addition of adjuvant and neoadjuvant regimens such as the regimen used in the recent MAGIC (Medical Research Council Adjuvant Gastric Infusional Chemotherapy) trial,1 as well as better disease stratification with the use of genetic profiles.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Case 2

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Case 2